This difference was attributed to rare prevalence in NOTCH-1 mutations in AML, and the fact that NOTCH-1 signaling inhibited a monocytic/granulocytic differentiation program in an early multipotent progenitor (Takam Kamga et al., 2019; Lobry et al., 2014). This evidence concerns the gene NOTCH1 and acute myeloid leukemia.